| Pharmaceutical active ingredients: |
| Ondansetron Hydrochloride |
| Available forms, composition and doses of Entron: |
| Injectable; Injection; Ondansetron Hydrochloride 2 mg / mlTablets, Film-Coated; Oral; Ondansetron Hydrochloride 8 mg |
| Entron medical category: |
| Human:5-HT3 Receptor AntagonistsAntiemeticsSupportive care therapy |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| A04AA01 - Ondansetron |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Ethica Industri Farmasi |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Dismolan | Ondansetron Hydrochloride | P. L. Rivero Laboratorios |
| Doran-O Injections | Ondansetron Hydrochloride | Bestochem Formulations India |
| Emeset | Ondansetron Hydrochloride | Cipla; CZ Pharma; Neopharm, Thailand |
| Emetron | Ondansetron Hydrochloride | Gedeon Richter |
| Emnil | Ondansetron Hydrochloride | Vilberry Healthcare |
| Fixca | Ondansetron Hydrochloride | Grupo Vita / Vita Cientifica |
| Helmine | Ondansetron Hydrochloride | GlaxoSmithKline |
| Izofran | Ondansetron Hydrochloride | GlaxoSmithKline |
| Izofran Zydis | Ondansetron Hydrochloride | GlaxoSmithKline |
| Jamp-Ondansetron | Ondansetron Hydrochloride | Jamp Pharma |